People
Aaron Kesselheim, a professor of Medicine at Harvard Medical School and has served on the advisory committee since 2015, has stepped down.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Two of the company’s largest shareholders call for the ouster of a company director at Regeneron as top executives are under fire for their enormous compensation packages.
David S. Knopman and Joel S. Perlmutter both resigned from the committee after the approval of the drug aducanumab.
John Edwards, newly-appointed CEO of Verseau Therapeutics, is continually searching for something special.
BioSpace recently spoke with Mir Imran, CEO and Chief Innovator at Rani Therapeutics, a company developing and testing a “robotic” pill that delivers biologics orally.
BioSpace caught up with Charles Fuchs, M.D., SVP, Global Head of Oncology & Hematology Product Development, Genentech during the ASCO meeting on personalized cancer care.
While several countries rely on Sinovac Biotech to end the pandemic, concerns regarding the shot’s efficacy continue to shroud the vaccine. Currently, it is the second most used vaccine worldwide.
Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.
Importantly, the researchers recovered virus that they were able to culture, indicating a high risk for transmissibility.
PRESS RELEASES